Information Journal Paper
APA:
Copy. (2019). Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer. BIOSCIENCE REPORTS, 39(7), 0-0. SID. https://sid.ir/paper/779159/en
Vancouver:
Copy. Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer. BIOSCIENCE REPORTS[Internet]. 2019;39(7):0-0. Available from: https://sid.ir/paper/779159/en
IEEE:
Copy, “Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer,” BIOSCIENCE REPORTS, vol. 39, no. 7, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/779159/en